Amyloid beta protein (25-35) stimulation of phospholipase C in LA-N-2 cells

被引:0
|
作者
Singh, IN
Sorrentino, G
Kanfer, JN
机构
[1] UNIV MANITOBA, DEPT BIOCHEM & MOL BIOL, WINNIPEG, MB R3E 0W3, CANADA
[2] UNIV NAPLES, FAC MED, IST SCI NEUROL, NAPLES, ITALY
关键词
Alzheimer's disease; amyloid beta protein; phospholipase C; receptor-mediated; inositol phosphates;
D O I
暂无
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The amyloid beta protein (25-35) stimulated appearance of H-3-inosilol phosphates from [H-3] inositol-prelabeled LA-N-2 cells was investigated. This stimulation was unaltered by extra- and intracellular calcium chelators in a calcium-free medium or by several protein kinase inhibitors. This phospholipase C stimulation by amyloid beta protein appeared to be pertussis toxin sensitive. It is possible that this phospholipase C stimulation by amyloid beta protein is a receptor-mediated process. This possibility is based on two related observations. The stimulation is ablated by the presence of conventional antagonists for metabotropic, adrenergic, and bombesin agonists. The IC50 values were 12 mu M for propranolol, 15 mu M for AP-3, and 25 nM for [Tyr(4),D-Phe(12)] bombesin. Additional support comes from results of densensitization and resensitization experiments. Amyloid beta protein stimulation of phospholipase C was absent from LA-N-2 cells previously treated with norepinephrine, trans-1-amino-1,3-cyclopentanedicarboxylic acid (t-ACPD), bombesin, or amyloid beta peptide. In a similar manner, LA-N-2 cells previously treated with amyloid beta protein were no longer responsive to norepinephrine, t-ACPD, or bombesin. The responsiveness to amyloid beta protein returned, subsequent to a period of resensitization for the individual agonists. It is suggested that this observed amyloid beta protein stimulation of phospholipase C may be responsible for the elevated quantity of inositol seen in the brains of Alzheimer's disease patients.
引用
收藏
页码:252 / 258
页数:7
相关论文
共 50 条
  • [21] INTRACEREBRAL BETA-AMYLOID(25-35) PRODUCES TISSUE-DAMAGE - IS IT NEUROTOXIC
    RUSH, DK
    ASCHMIES, S
    MERRIMAN, MC
    NEUROBIOLOGY OF AGING, 1992, 13 (05) : 591 - 594
  • [22] Amyloid Beta 25-35 induces blood-brain barrier disruption in vitro
    Cuevas, Elvis
    Rosas-Hernandez, Hector
    Burks, Susan M.
    Ramirez-Lee, Manuel A.
    Guzman, Aida
    Imam, Syed Z.
    Ali, Syed F.
    Sarkar, Sumit
    METABOLIC BRAIN DISEASE, 2019, 34 (05) : 1365 - 1374
  • [23] CORRELATION AMONG SECONDARY STRUCTURE, AMYLOID PRECURSOR PROTEIN ACCUMULATION, AND NEUROTOXICITY OF AMYLOID BETA(25-35) PEPTIDE AS ANALYZED BY SINGLE ALANINE SUBSTITUTION
    SATO, K
    WAKAMIYA, A
    MAEDA, T
    NOGUCHI, K
    TAKASHIMA, A
    IMAHORI, K
    JOURNAL OF BIOCHEMISTRY, 1995, 118 (06) : 1108 - 1111
  • [24] APOPTOSIS MEDIATED NEUROTOXICITY INDUCED BY CHRONIC APPLICATION OF BETA-AMYLOID FRAGMENT 25-35
    FORLONI, G
    CHIESA, R
    SMIROLDO, S
    VERGA, L
    SALMONA, M
    TAGLIAVINI, F
    ANGERETTI, N
    NEUROREPORT, 1993, 4 (05) : 523 - 526
  • [25] Antioxidant effects of Epicatechin on the hippocampal toxicity caused by Amyloid-beta 25-35 in rats
    Cuevas, Elvis
    Limon, Daniel
    Perez-Severiano, Francisca
    Diaz, Alfonso
    Ortega, Laura
    Zenteno, Edgar
    Guevara, Jorge
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2009, 616 (1-3) : 122 - 127
  • [26] Amyloid β-peptide(25-35) changes [Ca2+] in hippocampal neurons
    Mogensen, HS
    Beatty, DM
    Morris, SJ
    Jorgensen, OS
    NEUROREPORT, 1998, 9 (07) : 1553 - 1558
  • [27] Gene Expression Analysis of the Human Astrocytoma Cell after A beta(25-35) Stimulation Followed by Ibuprofen Administration
    Choi, Youngsook
    Eun, Jungwoo
    Nam, Sukwoo
    Kim, Sangho
    ANNALS OF GERIATRIC MEDICINE AND RESEARCH, 2011, 15 (03): : 144 - 161
  • [28] Mechanism of soluble beta-amyloid 25-35 neurotoxicity in primary cultured rat cortical neurons
    Wang, Yong
    Liu, Lili
    Hu, Weimin
    Li, Guanglai
    NEUROSCIENCE LETTERS, 2016, 618 : 72 - 76
  • [29] BETA-AMYLOID(25-35) INDUCES THE PRODUCTION OF INTERLEUKIN-8 FROM HUMAN MONOCYTES
    MEDA, L
    BONAIUTO, C
    SZENDREI, GI
    CESKA, M
    ROSSI, F
    CASSATELLA, MA
    JOURNAL OF NEUROIMMUNOLOGY, 1995, 59 (1-2) : 29 - 33
  • [30] Effect of the beta-sheet-breaker peptide LPFFD on oriented network of amyloid β25-35 fibrils
    Murvai, Unige
    Soos, Katalin
    Penke, Botond
    Kellermayer, Miklos S. Z.
    JOURNAL OF MOLECULAR RECOGNITION, 2011, 24 (03) : 453 - 460